Current Ratio
since 2012
Calculation
AbbVie Inc., current ratio, long-term trends, calculation
| Current ratio | = | Current assets1 | ÷ | Current liabilities1 | |
|---|---|---|---|---|---|
| Dec 31, 2023 | 0.87 | = | 33,002) | ÷ | 37,841) |
| Dec 31, 2022 | 0.96 | = | 28,463) | ÷ | 29,538) |
| Dec 31, 2021 | 0.79 | = | 27,928) | ÷ | 35,194) |
| Dec 31, 2020 | 0.84 | = | 24,173) | ÷ | 28,661) |
| Dec 31, 2019 | 3.18 | = | 49,519) | ÷ | 15,585) |
| Dec 31, 2018 | 0.98 | = | 16,945) | ÷ | 17,239) |
| Dec 31, 2017 | 1.28 | = | 21,223) | ÷ | 16,641) |
| Dec 31, 2016 | 1.65 | = | 16,187) | ÷ | 9,781) |
| Dec 31, 2015 | 1.50 | = | 16,314) | ÷ | 10,894) |
| Dec 31, 2014 | 1.41 | = | 16,088) | ÷ | 11,400) |
| Dec 31, 2013 | 2.59 | = | 17,848) | ÷ | 6,879) |
| Dec 31, 2012 | 2.27 | = | 15,354) | ÷ | 6,776) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).
1 US$ in millions
Comparison to Competitors
AbbVie Inc., current ratio, long-term trends, comparison to competitors
| AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Moderna Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2023 | 0.87 | 1.65 | 1.43 | 1.68 | 0.94 | 1.43 | 1.16 | 1.25 | 3.42 | 0.91 | 5.69 | 1.75 |
| Dec 31, 2022 | 0.96 | 1.41 | 1.25 | 1.89 | 1.05 | 1.29 | 0.99 | 1.47 | 2.73 | 1.22 | 5.06 | 1.48 |
| Dec 31, 2021 | 0.79 | 1.59 | 1.52 | 1.43 | 1.23 | 1.27 | 1.35 | 1.27 | 1.76 | 1.40 | 3.56 | 1.50 |
| Dec 31, 2020 | 0.84 | 1.81 | 1.58 | 1.86 | 1.40 | 1.40 | 1.21 | 1.02 | 1.43 | 1.35 | 3.63 | 2.13 |
| Dec 31, 2019 | 3.18 | 1.44 | 1.60 | 5.19 | 1.16 | 3.10 | 1.26 | 1.24 | 7.89 | 0.88 | 3.67 | 1.92 |
| Dec 31, 2018 | 0.98 | 2.79 | 1.61 | 1.47 | 1.73 | 3.38 | 1.47 | 1.17 | 7.02 | 1.57 | 4.47 | 1.73 |
| Dec 31, 2017 | 1.28 | 5.49 | 1.55 | 1.43 | 1.32 | 2.74 | 1.41 | 1.33 | — | 1.35 | 3.82 | 1.34 |
| Dec 31, 2016 | 1.65 | 4.11 | 1.55 | 0.97 | 1.37 | 2.22 | 2.47 | 1.78 | — | 1.25 | 2.56 | 1.44 |
| Dec 31, 2015 | 1.50 | 4.44 | 1.30 | 1.27 | 1.53 | 2.50 | 2.17 | 1.55 | — | 1.49 | 3.59 | 1.38 |
| Dec 31, 2014 | 1.41 | 4.95 | 1.73 | 1.75 | 1.09 | 3.07 | 2.36 | 1.77 | — | 2.67 | 3.31 | 1.22 |
| Dec 31, 2013 | 2.59 | 3.44 | 1.52 | 2.01 | 1.47 | 1.15 | 2.20 | 2.00 | — | 2.41 | 6.01 | 3.16 |
| Dec 31, 2012 | 2.27 | 3.81 | 1.15 | 1.80 | 1.55 | 1.44 | 1.90 | 1.90 | — | 2.15 | 7.37 | 2.31 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
AbbVie Inc., current ratio, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| AbbVie Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Dec 31, 2023 | 0.87 | 1.26 |
| Dec 31, 2022 | 0.96 | 1.29 |
| Dec 31, 2021 | 0.79 | 1.35 |
| Dec 31, 2020 | 0.84 | 1.35 |
| Dec 31, 2019 | 3.18 | 1.66 |
| Dec 31, 2018 | 0.98 | 1.70 |
| Dec 31, 2017 | 1.28 | 1.73 |
| Dec 31, 2016 | 1.65 | 1.91 |
| Dec 31, 2015 | 1.50 | 1.90 |
| Dec 31, 2014 | 1.41 | 2.18 |
| Dec 31, 2013 | 2.59 | 2.16 |
| Dec 31, 2012 | 2.27 | 2.04 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).
Comparison to Industry (Health Care)
AbbVie Inc., current ratio, long-term trends, comparison to industry (health care)
| AbbVie Inc. | Health Care | |
|---|---|---|
| Dec 31, 2023 | 0.87 | 1.14 |
| Dec 31, 2022 | 0.96 | 1.16 |
| Dec 31, 2021 | 0.79 | 1.21 |
| Dec 31, 2020 | 0.84 | 1.21 |
| Dec 31, 2019 | 3.18 | 1.34 |
| Dec 31, 2018 | 0.98 | 1.38 |
| Dec 31, 2017 | 1.28 | 1.47 |
| Dec 31, 2016 | 1.65 | 1.68 |
| Dec 31, 2015 | 1.50 | 1.67 |
| Dec 31, 2014 | 1.41 | 1.87 |
| Dec 31, 2013 | 2.59 | 1.93 |
| Dec 31, 2012 | 2.27 | 1.81 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31).